Good morning :)
Switch to
Place Order

Lincoln Pharmaceuticals Ltd

LINCOLN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹768 cr, stock is ranked 1,030
Moderate RiskStock is 2.60x as volatile as Nifty
384.3010.10 (-2.56%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹768 cr, stock is ranked 1,030
Moderate RiskStock is 2.60x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
12.35
PB RatioPB Ratio
2.45
Dividend YieldDiv. Yield
0.39%
Sector PESector PE
40.41
Sector PBSector PB
5.41
Sector Div YldSctr Div Yld
0.64%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021366.07371.78397.53429.8534.6448.7151.4262.22
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 4.37%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnSep 16, 2021

Lincoln Pharmaceuticals Limited has informed the Exchange regarding 'Media Release on approval of scheme of amalgamation of Lincoln Parenteral Ltd and Lincoln Pharmaceuticals Ltd.'. | Download

Lincoln Pharmaceuticals Limited has informed the Exchange regarding 'Media Release on approval of scheme of amalgamation of Lincoln Parenteral Ltd and Lincoln Pharmaceuticals Ltd.'. | Download

Scheme of Arrangement 
Announced OnSep 16, 2021

Lincoln Pharmaceuticals Limited has informed the Exchange about Scheme of Arrangement of Lincoln Parenteral Limited ( Transferor Company ) and Lincoln Pharmaceuticals Limited ( Transferee Company ) and their respective shareholders and creditors vide its order dated September 14, 2021 and has been uploaded on the website of Hon'ble NCLT on September 15, 2021. | Download

Lincoln Pharmaceuticals Limited has informed the Exchange about Scheme of Arrangement of Lincoln Parenteral Limited ( Transferor Company ) and Lincoln Pharmaceuticals Limited ( Transferee Company ) and their respective shareholders and creditors vide its order dated September 14, 2021 and has been uploaded on the website of Hon'ble NCLT on September 15, 2021. | Download

Cash Dividend 
Ex. DateSep 16, 2021

Final • Div/Share: ₹ 1.5

See all events